Grifols S.A.
Develops and produces plasma-derived medicines and biopharmaceutical solutions.
GRF | MC
Overview
Corporate Details
- ISIN(s):
- ES0171996087 (+4 more)
- LEI:
- 959800HSSNXWRKBK4N60
- Country:
- Spain
- Address:
- Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
- Website:
- https://www.grifols.com/en/home
- Sector:
- Manufacturing
Description
Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-21 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2024-06-18 13:20 |
Grifols informa del cierre de la transacción en China con Haier Group Corporati…
|
Spanish | 68.2 KB | ||
| 2024-06-14 13:42 |
Junta General Ordinaria 2024.
|
Spanish | 457.7 KB | ||
| 2024-06-04 16:30 |
La Sociedad informa el cierre con éxito de la colocación privada de bonos senio…
|
Spanish | 41.5 KB | ||
| 2024-05-31 15:40 |
Cambio de categoría de consejeros.
|
Spanish | 39.7 KB | ||
| 2024-05-14 17:37 |
Grifols comunica la información financiera correspondiente al primer trimestre …
|
Spanish | 980.4 KB | ||
| 2024-05-10 08:01 |
Convocatoria de la Junta General Ordinaria 2024 de Grifols, S.A.
|
Spanish | 139.2 KB | ||
| 2024-05-07 18:24 |
El Consejo de Administración de la Sociedad ha adoptado, por unanimidad, divers…
|
Spanish | 193.0 KB | ||
| 2024-05-06 11:32 |
Como continuación de la información facilitada al mercado Grifols informa que a…
|
Spanish | 39.9 KB | ||
| 2024-04-30 15:28 |
Grifols informa que los Bonos han sido emitidos y que la emisión ha quedado sat…
|
Spanish | 92.5 KB | ||
| 2024-04-23 08:43 |
La Sociedad comunica la firma, sujeta a las condiciones habituales de cierre, d…
|
Spanish | 93.2 KB | ||
| 2024-04-18 15:04 |
Cambio de Secretario de la Comisión de Auditoría de la Sociedad.
|
Spanish | 44.3 KB | ||
| 2024-04-10 08:31 |
Grifols S.A. desea informar al mercado que está trabajando activamente para emi…
|
Spanish | 94.2 KB | ||
| 2024-04-04 23:21 |
Aclaración a los requerimientos de la CNMV 04.04.24
|
Spanish | 38.9 KB | ||
| 2024-04-02 08:45 |
D. José Ignacio (Nacho) Abia ha pasado a tener la categoría de "consejero ejecu…
|
Spanish | 39.3 KB |
Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Grifols S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Grifols S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
